Bayer: Science For A Better Life
 
Special Interests
26-févr.-2010
Succès pour Bayer dans un contexte difficile
2009: opérationnellement une des années les plus fortes - optimisme pour l'avenir
 

Group sales EUR 31,168 million (minus 5.3 percent) / EBITDA before special items EUR 6,472 million (minus 6.6 percent) / Net income EUR 1,359 million (minus 20.9 percent) / Net cash flow significantly improved to EUR 5,375 million (plus 49 percent) / Net financial debt reduced by EUR 4.5 billion to EUR 9.7 billion / Core earnings per share expected to improve by about 10 percent in 2010.

 

Read more about the Annual Report 2009